All In Biotech

Free tool

FAERS Monitor: Nitrogen, Nf

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205839 or its brand name (Nitrogen, Nf, Nitrogen). Reports on generic versions are filed under their own applications.

Reports

111

Serious

94

85% of reports

Hospitalization

33

Death reported

14

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malaise10
  • off label use10
  • drug interaction7
  • accidental exposure to product6
  • psoriasis6
  • completed suicide5
  • dyspnoea5
  • haemodynamic instability5
  • nausea5
  • product leakage5
  • ventricular fibrillation5
  • weight decreased5
  • death4
  • dry gangrene4
  • extremity necrosis4

Reports by year received

View as table
YearReports
20041
20051
20061
20071
20101
20111
20123
20132
20142
20154
20169
201713
201815
20195
20202
20214
20227
202315
202410
20254
202610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,048 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dry gangreneSignal41202.4457.93,652
extremity necrosisSignal4435.5166.21,324
product leakageSignal5169.071.7675
haemodynamic instabilitySignal5124.452.8495
ventricular fibrillationSignal585.336.2337
completed suicideSignal511.44.838
accidental exposure to productSignal611.05.145
psoriasisSignal68.74.034
drug interactionSignal78.44.139
malaiseSignal104.32.423
weight decreasedSignal53.41.46
off label useSignal102.21.25
dyspnoea51.70.71
nausea51.20.50
death40.90.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.